Opana ER Endo Pharmaceuticals Inc. - Treatment for Moderate-to-Severe Pain

Opana ER (extended-release) and Opana (immediate-release) are oral formulations of the opioid analgesic oxymorphone, used for the relief of moderate-to-severe pain. Opana ER is indicated for patients requiring continuous, around-the-clock opioid treatment for an extended period of time, and Opana is indicated for the relief of acute pain where the use of an opioid is appropriate.

Related Articles:

Endo Files Responses to FDA's Approvable Letters on NDAs for Oxymorphone ER and IR Tablets - December 22, 2005

Latest FDA Drug Approvals...

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals